AbbVie brain cancer drug fails late-stage study in another oncology setback

Al's Comment:

 So sad to hear of another clinical trial failure of a gbm drug.  They did not release the details yetso we do not know if it is worth trying it in some other way or in combinations with other drugs yet.


Posted on: 05/17/2019

AbbVie brain cancer drug fails late-stage study in another oncology setback

 


Click HERE to return to brain tumor news headlines